Quoin Pharmaceuticals Ltd. Debt Securities, Trading, and Equity Securities, FV-NI
Quoin Pharmaceuticals Ltd. (QNRX) had Debt Securities, Trading, and Equity Securities, FV-NI of $14.90 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes
us-gaap:TradingSecurities · last filed 2026-03-26
- 2025-12-31: Debt Securities, Trading, and Equity Securities, FV-NI $14.90M.
- 2025-09-30: Debt Securities, Trading, and Equity Securities, FV-NI $3.60M.
- 2025-06-30: Debt Securities, Trading, and Equity Securities, FV-NI $6.10M.
- 2025-03-31: Debt Securities, Trading, and Equity Securities, FV-NI $7.70M.
| Period end | Debt Securities, Trading, and Equity Securities, FV-NI | Debt Securities, Trading, and Equity Securities, FV-NI as first filed |
|---|---|---|
| 2025-12-31 | $14.90M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $3.60M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $6.10M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $7.70M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $10.40M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $7.20M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $9.70M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $12.90M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $8.30M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $10.80M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $10.70M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $13.60M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $10.00M 10-K · filed 2024-03-14 | $9.90M 10-K · filed 2023-03-15 |
| 2022-09-30 | $9.90M 6-K · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |